ARTICLE | Clinical News
BioSante, Medi-Ject preclinical data
August 14, 2000 7:00 AM UTC
The companies said that a DNA vaccine encoding viral proteins formulated with BTPH's CAP technology and delivered intramuscularly with MEDJ's needle-free injection system produced significant cellular...